logo 600X600.png
Global Pulmonary Surfactant Market to Surpass US$ 822.9 Million by 2030, Says Coherent Market Insights (CMI)
05 janv. 2023 08h40 HE | CMI
Burlingame, Jan. 05, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global pulmonary surfactant market is estimated to be valued at US$ 578.7 million in 2022 and is expected to...
3DR Labs, an Accumen
3DR Labs, an Accumen Company, Announces a New Partnership with Imbio to bring its AI-based Lung Imaging Technology to Health Systems Nationally
09 déc. 2020 12h00 HE | Accumen Inc
Phoenix, AZ, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Accumen is helping healthcare get better, faster. Today, 3DR Labs, an Accumen Company, announced that it is now offering an artificial intelligence...
Aerobika-004 (1) copy
Monaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment Option
07 janv. 2020 08h40 HE | Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika®...
Intermediate Mask Product Shot
Monaghan Medical Corporation Introduces an Intermediate-Size Mask
05 juin 2019 08h45 HE | Monaghan Medical Corporation
PLATTSBURGH, N.Y., June 05, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue their mission to ensure device quality for patients....
Better Understand Chronic Obstructive Pulmonary Disease With Free Guide From Do More With Oxygen
16 juil. 2013 07h03 HE | Do More With Oxygen
CLEVELAND, OH--(Marketwired - Jul 16, 2013) - An estimated 24 million Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), a progressive disease that makes it difficult to breathe....